(Unaudited data)
- Cumulative activity as of the end of december 2014
thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
France | 346,965 | 343,891 | - 0.9% | - 0.9% |
International : | 270,766 | 265,857 | - 1.8% | + 2.7% |
Incl. Europe excluding France | 204,283 | 198,918 | - 2.6% | + 2.8% |
Incl. North America | 53,364 | 52,813 | - 1.0% | + 0.3% |
Incl. Other countries | 13,119 | 14,126 | + 7.7% | + 9.6% |
Group Total | 617,731 | 609,748 | - 1.3% | + 0.7% |
thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
Non-proprietary Homeopathic Medicines | 305,739 | 305,501 | - 0.1% | + 0.0% |
OTC Specialties | 311,581 | 303,549 | - 2.6% | + 1.2% |
Other | 411 | 698 | + 69.8% | + 67.6% |
Group Total | 617,731 | 609,748 | - 1.3% | + 0.7% |
- Quarterly activity in 2014 ( variation at current rate)
1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter | |||||||||
thousands of euros | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 |
France | 84,270 | 82,749 | - 1.8% | 75,327 | 74,269 | - 1.4% | 92,596 | 92,466 | - 0.1% | 94,772 | 94,407 | - 0.4% |
International : | 73,751 | 57,460 | -22.1% | 42,436 | 47,138 | +11.1% | 76,890 | 79,646 | +3.6% | 77,689 | 81,613 | +5.1% |
Incl.Europe excluding France | 54,334 | 39,967 | - 26.4% | 29,047 | 33,570 | + 15.6% | 61,256 | 62,758 | + 2.5% | 59,646 | 62,623 | +5.0% |
Incl. North America | 15,562 | 12,662 | - 18.6% | 10,017 | 10,625 | + 6.1% | 12,153 | 13,109 | + 7.9% | 15,632 | 16,417 | +5.0% |
Incl. Other countries | 3,855 | 4,831 | +25.3% | 3,372 | 2,943 | - 12.7% | 3,481 | 3,779 | + 8.6% | 2,411 | 2,573 | +6.7% |
Group Total | 158,021 | 140,209 | -11.3% | 117,763 | 121,407 | + 3.1% | 169,486 | 172,112 | +1.5% | 172,461 | 176,020 | +2.1% |
1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter | |||||||||
thousands of euros | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 | 2013 | 2014 | Var. 14/13 |
Non-proprietary Homeopathic Medicines | 79,062 | 77,919 | - 1.4% | 73,035 | 73,072 | + 0.1% | 73,597 | 72,957 | - 0.9% | 80,045 | 81,553 | + 1.9% |
OTC Specialties | 78,866 | 62,196 | -21.1% | 44,600 | 48,058 | + 7.8% | 95,813 | 99,025 | + 3.4% | 92,302 | 94,270 | + 2.1% |
Other | 93 | 94 | +1.1% | 128 | 277 | +116.4% | 76 | 130 | +71.1% | 114 | 197 | +72.8% |
Group Total | 158,021 | 140,209 | -11.3% | 117,763 | 121,407 | + 3.1% | 169,486 | 172,112 | + 1.5% | 172,461 | 176,020 | + 2.1% |
Highlights of the fourth quarter
- Sales revenue in the fourth quarter of 2014 grew by 2.1% (5.1% at constant rate).
- Given the evolution of business and the control of costs, the 2014 operating income should grow in comparison to 2013.
- On December 31, 2013, the group's net cash position is close to 156 million euros.
On January 19, 2015, the Superior Court of Montreal rejected the complaint aiming at launching a class action proceeding filed on April 13, 2012.
Our next update: March 18, 2015, after the close of the stock market, publication of 2014 results.
Financial information manager: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at : www.boironfinance.com
Communiqués au titre de l′obligation d′information permanente :
- Communiqué sur comptes, résultats, chiffres d′affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-38559-BOI-220115-CA-14-GB.pdf
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it′s free
© 2015 ActusNews